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tancy; andFor most readers of “Vaccine,” it is a truism that vaccines
epresent one of the safest and most effective tools available in
lobal efforts to control and prevent infectious diseases. Yet, par-
nts searching the Internet about whether or not it is safe to get
hemselves or their children vaccinated will ﬁnd this consensus
ecast as a controversy, or even a conspiracy. Many of the top
nternet search results question or dispute the scientiﬁc consen-
us about the safety and effectiveness of some or all vaccines
n a number of grounds, from secular to religious to political-
hilosophical. The gap between expert consensus and the thinking
mong many publics around the world is not limited to the Internet.
he proliferation of conﬂicting information and the ease with which
isinformation can amplify — via old and new media channels —
rovide a confusing context for parents seeking additional guidance
rom health workers, religious leaders, family members, or other
rusted sources, many of whom may  themselves be misinformed
bout the risks and beneﬁts of vaccines. In this context, perhaps it is
ot surprising that some caregivers have become “hesitant” about
ecisions to vaccinate.
Drawing on examples from around the world, in richer and
oorer countries alike, the papers in this Special Issue demonstrate
hat there is no single form that vaccine hesitancy takes, and that
he reasons behind decisions to delay or refuse vaccination are
ighly variable and context speciﬁc. Skepticism and rejection of
accines among a portion of the public is as old as vaccine technol-
gy itself. But there are reasons to believe that new dynamics in the
arly 21st century have made the question of how to address vac-
ine hesitancy more acute, including the accelerated introduction
f additional vaccines into routine programs, high-proﬁle global
nitiatives to bring the beneﬁts of immunization to the one-in-ﬁve
hildren in developing countries who currently do not receive those
eneﬁts, and tectonic shifts in the production and consumption of
nformation associated with the emergence and global penetration
f social media. These dynamics set the backdrop for the request by
he Strategic Advisory Group of Experts (SAGE) on Immunization
o establish a working group on vaccine hesitancy. As vaccine hesi-
ancy trends persist and associated risks have arguably increased in
ecent years, this supplement represents a timely contribution to
he state of knowledge regarding “vaccine hesitancy” halfway into
he Decade of Vaccines (2011–2020).
The introductory article in this Special Issue summarizes the his-
ory and rationale for SAGE’s initial request to establish a Working
roup on Vaccine Hesitancy in March 2012. It notes that reports
bout declining public trust and acceptance of vaccines and/or
ttp://dx.doi.org/10.1016/j.vaccine.2015.04.034
264-410X/© 2015 Published by Elsevier Ltd. This is an open access article under the CC Bimmunization programs in some settings are longstanding issues.
Since 2001, SAGE has repeatedly acknowledged the need to address
the gap between public perceptions of vaccines and the consen-
sus of the scientiﬁc and public health communities. By 2008–2009,
SAGE reports explicitly recognized the need to actively pursue more
methodical and proactive strategies to address misinformation
propagated by increasingly vocal and sophisticated anti-vaccine
movements, particularly in Europe. By the beginning of the Decade
of Vaccines, experiences from polio eradication programs in India
and Nigeria made it clear that vaccine hesitancy, public mistrust
of vaccines and immunization services, and outright rejection of
vaccines, are global issues that threaten to undermine decades of
progress, the achievement of Millennium Development Goals, and
the objectives of the Global Vaccine Action Plan (2011–2020).
Led by a joint WHO  and UNICEF Secretariat, the SAGE Vaccine
Hesitancy Working Group issued its ﬁnal report to SAGE in October
2014. SAGE endorsed the proposed deﬁnition of vaccine hesitancy
as “[a] delay in acceptance or refusal of vaccines despite availability
of vaccination services. Vaccine hesitancy is complex and context
speciﬁc, varying across time, place and vaccines [and] includes
factors such as complacency, convenience and conﬁdence.” This
Special Issue includes many of the products, conclusions, and rec-
ommendations endorsed by SAGE based on the Working Group’s
progress, including:
(1) the deﬁnition of vaccine hesitancy and delineation of its com-
ponents and potential determinants;
(2) an account of attempts to develop and pilot indicators to mea-
sure the scale and character of hesitancy in order to inform
the development of strategies and policies and measure the
effectiveness of interventions;
(3) suggested steps for adapting the Guide to Tailoring Immuniza-
tion Programmes (WHO EURO) into a more widely applicable
diagnostic resource for generating behavioral insights and iden-
tifying the determinants of vaccine hesitancy among speciﬁc
subgroups in particular contexts anywhere in the world;
(4) an examination of social and commercial marketing applica-
tions with consideration of their potential to contribute to
interventions to address vaccine hesitancy;
(5) systematic reviews of past strategies to address vaccine hesi-(6) a brief synopsis of four lessons from the ﬁeld of health com-
munication that are applicable to efforts to address vaccine
hesitancy.
Y license (http://creativecommons.org/licenses/by/3.0/).
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Taken collectively, these papers provide a sense of the current
tate of understanding regarding vaccine hesitancy as well as a set
f high-level recommendations for next steps. They highlight the
eed to continue to reﬁne our understanding of vaccine hesitancy,
ncluding the many forms it can take, the implications it may  have
n different contexts, its proximal and distal causes, and the chang-
ng nature of both the challenge and potential solutions in light of
merging technologies, a rapidly evolving global media environ-
ent, and an ever-changing geopolitical terrain. SAGE highlights
he urgent need to develop institutional structures and organiza-
ional capacity at local, national and global levels to proactively
ddress vaccine hesitancy and prepare for timely response in the
vent of rumors, media misinformation, adverse events following
mmunization (AEFI), or organized anti-vaccine movements. They
lso highlight the need to couple strategies to tackle vaccine hes-
tancy with efforts to tailor service delivery to match local needs
nd cultural practices. This issue of Vaccine represents a prelim-
nary step towards critically needed initiatives to systematically
hare experiences between organizations and contexts, document
nd build on what works, and develop, validate, implement, and
isseminate new tools and resources to deal with a problem that
hows no sign of abating.
Looking across the articles and reﬂecting on lessons learned
rom other public education initiatives to engage resistant commu-
ities in productive dialogue or to counter misinformation about
ritical public health and development issues (e.g. polio eradication,
obacco, HIV), a number of additional themes and recommenda-
ions emerge that deserve highlighting. For example, it becomes
lear that reaching out to and involving a broader range of stake-
olders needs to take place earlier in processes of decision-making
nd communicating about the organization and delivery of immu-
ization services or activities like the introduction of new vaccines
r the extension of immunization services to non-traditional popu-
ations (e.g. adolescents). Too often, this sort of outreach is only
one in reaction to a problem that has ﬁnally grown too big to
gnore. To riff on an immunization key message: prevention is
etter—and cheaper—than treatment. WHO  and UNICEF will con-
inue to work with our national counterparts to be proactive about
his outreach, inclusive and open-minded about who should be
ounted as a stakeholder, and make sure all parties are supported in
heir efforts to sustain the channels of dialogue and sense of mutual
wnership we are collectively working to establish.The time has come to act on—and invest in—the SAGE rec-
mmendation that key immunization partners align their efforts
o develop local, national, and global capacities in ﬁelds out-
ide of the traditional remit of immunization programs, including015) 4155–4156
medical anthropology, social and behavior change communication,
opinion research, behavioral economics, commercial and social
marketing, and user-centered design research. It is not an effective
formula to have vaccine hesitancy be addressed by one organiza-
tion or department, whilst plans and activities to introduce new
vaccines, enhance coverage, or reduce inequities in uptake are
undertaken in isolation by another. A clear lesson from the exam-
ples in this Special Issue is that immunization programs must
systematically and comprehensively address not only supply-side
but also demand-side strategies, and do so from inception through
implementation.
As the recent Ebola crisis tragically brought to light, engag-
ing with communities and persuading individuals to change their
habits and behaviors is a lynchpin of public health success.
Addressing vaccine hesitancy is no different. Proactive prepara-
tion and nimble response based on social and behavioral insights
requires analytical capacity to detect, assess, and address “hotspot”
areas of hesitancy that can quickly become explosive; ongoing
engagement with social actors (i.e. media; opinion leaders) that
shape public perceptions of risk and safety of vaccines; and prede-
ﬁned roles, prepositioned resources, and crisis mitigation plans that
can be triggered to effectively address rumors or misinformation
before they adversely affect uptake.
Although this Special Issue focuses on vaccine and vaccination
hesitancy, it is important to see the work on hesitancy as only one
aspect of a broader agenda of generating public trust in and demand
for immunization. One of the six primary strategic objectives in the
Global Vaccine Action Plan calls for “individuals and communities
to understand the value of vaccines and demand immunization
as both their right and responsibility.”1 Achieving this objective
requires going beyond addressing vaccine hesitancy issues. But the
better we understand the issues described in this Special Issue and
the smarter we  are about capitalizing on the opportunities that
come with the associated SAGE recommendations, the closer we are
to tackling the broader agenda of enhancing and sustaining public
demand for immunization.
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